Other tested variables including tumor suppressors, oncogenes, individual genes, gene loci (including other TP53 exons), as well as the degree of heterogeneity of index lesions, were not shown to be statistically significant predictors of the risk of metachronous adenomas. The gene discussed is TP53; the disease is adenoma.